Profile data is unavailable for this security.
About the company
CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.
- Revenue in JPY (TTM)193.68m
- Net income in JPY-892.21m
- Incorporated2001
- Employees35.00
- LocationCellSeed Inc15FTelecom Center East Bldg., 2-5-10, AomiKOTO-KU 135-0064JapanJPN
- Phone+81 363807490
- Fax+81 363807491
- Websitehttps://www.cellseed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DNA Chip Research Inc | 490.46m | -248.29m | 6.10bn | 36.00 | -- | 8.32 | -- | 12.43 | -39.09 | -39.09 | 77.17 | 108.27 | 0.5292 | 9.84 | 3.11 | -- | -26.79 | -23.49 | -32.60 | -26.70 | 13.53 | 14.28 | -50.62 | -54.10 | 2.92 | -2,206.97 | -- | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
NIPPON CHEMIPHAR CO., LTD. | 30.75bn | -180.00m | 6.69bn | 872.00 | -- | 0.3071 | 5.73 | 0.2177 | -49.89 | -49.89 | 8,520.20 | 5,115.78 | 0.6268 | 2.14 | 2.70 | -- | -0.3689 | 0.7482 | -0.5204 | 1.08 | 25.17 | 30.99 | -0.5887 | 1.13 | 1.53 | -- | 0.4791 | 50.33 | -2.57 | -2.10 | -153.10 | -- | 24.62 | -12.94 |
MEDRx Co Ltd | 22.57m | -770.66m | 6.99bn | 22.00 | -- | 3.32 | -- | 309.57 | -20.97 | -20.97 | 0.6128 | 47.84 | 0.0143 | 0.00 | 4.22 | 1,025,955.00 | -48.80 | -58.15 | -50.27 | -62.23 | 100.00 | 95.70 | -3,414.38 | -1,526.17 | 43.57 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
Chiome Bioscience Inc | 642.70m | -1.30bn | 6.99bn | 51.00 | -- | 5.54 | -- | 10.87 | -25.56 | -25.56 | 12.60 | 22.39 | 0.3348 | 4.27 | 8.96 | 12,602,040.00 | -67.53 | -50.50 | -88.83 | -57.38 | 55.96 | 57.53 | -201.70 | -224.74 | 3.46 | -629.88 | 0.2009 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
Carna Biosciences, Inc. | 1.58bn | -1.03bn | 7.15bn | 67.00 | -- | 1.93 | -- | 4.53 | -60.32 | -60.32 | 92.24 | 205.19 | 0.3574 | 1.24 | 12.63 | 23,578,990.00 | -23.36 | -14.45 | -25.26 | -16.95 | 89.03 | 90.59 | -65.36 | -35.42 | 13.18 | -- | 0.0326 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
Symbio Pharmaceuticals Ltd | 4.64bn | -2.74bn | 7.16bn | 109.00 | -- | 0.9976 | -- | 1.54 | -66.88 | -66.88 | 113.80 | 156.38 | 0.5439 | 2.76 | 5.14 | 42,594,130.00 | -32.15 | -19.18 | -35.33 | -23.62 | 78.38 | 65.84 | -59.12 | -24.32 | 10.43 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
Veritas In Silico Inc | -100.00bn | -100.00bn | 7.52bn | 15.00 | -- | 3.19 | -- | -- | -- | -- | -- | 363.52 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 40.94 | -- | 0.00 | -- | 101.54 | -- | 123.38 | -- | -- | -- |
K Pharma Inc | 500.00m | -221.98m | 8.24bn | 15.00 | -- | 2.87 | -- | 16.48 | -18.94 | -18.94 | 43.04 | 247.43 | 0.2095 | 4.49 | -- | 33,333,330.00 | -9.30 | -- | -9.83 | -- | 91.00 | -- | -44.40 | -- | 42.60 | -- | 0.00 | -- | -- | -- | 166.34 | -- | -- | -- |
CellSeed Inc | 193.68m | -892.21m | 8.31bn | 35.00 | -- | 3.89 | -- | 42.93 | -29.71 | -29.71 | 6.47 | 64.75 | 0.088 | 1.63 | 7.62 | 5,533,600.00 | -40.53 | -49.69 | -43.83 | -54.55 | 56.58 | 63.66 | -460.67 | -428.62 | 19.14 | -- | 0.0669 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
TMS Co Ltd | 0.00 | -960.04m | 8.83bn | 14.00 | -- | 2.55 | -- | -- | -25.89 | -25.89 | 0.00 | 85.77 | 0.00 | -- | -- | 0.00 | -26.14 | -- | -26.78 | -- | -- | -- | -- | -- | -- | -2,219.42 | 0.00 | -- | -- | -- | -11.51 | -- | -- | -- |
Wakamoto Pharmaceutical Co Ltd | 7.74bn | 108.96m | 8.85bn | 292.00 | 80.91 | 0.733 | 90.51 | 1.14 | 3.14 | 3.14 | 222.97 | 346.51 | 0.4971 | 2.09 | 2.57 | -- | 0.70 | -2.28 | 0.8046 | -2.64 | 46.52 | 51.00 | 1.41 | -3.97 | 3.85 | -- | 0.0083 | -- | -10.65 | -6.35 | -21.19 | -- | 4.93 | -- |
Kohjin Bio Co Ltd | 4.77bn | 384.98m | 9.03bn | 157.00 | 23.01 | 2.65 | 22.14 | 1.89 | 76.77 | 76.77 | 951.17 | 666.48 | -- | -- | -- | -- | -- | -- | -- | -- | 39.44 | -- | 8.07 | -- | 1.14 | -- | 0.4249 | -- | 0.5715 | -- | -53.61 | -- | -- | -- |
Tsubota Laboratory Inc | 673.53m | -641.32m | 9.34bn | 10.00 | -- | 6.83 | -- | 13.86 | -25.15 | -25.15 | 26.42 | 53.45 | 0.2711 | 2.04 | 37.74 | -- | -25.82 | -- | -36.41 | -- | 3.17 | -- | -95.22 | -- | 2.31 | -489.86 | 0.0788 | -- | -29.45 | -- | -811.14 | -- | -- | -- |
CanBas Co Ltd (Parent) | 0.00 | -1.09bn | 9.52bn | 12.00 | -- | 3.18 | -- | -- | -64.47 | -64.47 | 0.00 | 166.10 | 0.00 | -- | -- | 0.00 | -43.91 | -65.86 | -45.99 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
Linical Co Ltd | 12.31bn | 338.27m | 9.82bn | 759.00 | 26.51 | 1.09 | 11.47 | 0.798 | 14.98 | 14.98 | 544.93 | 364.60 | 0.6837 | -- | 3.59 | -- | 1.88 | 4.01 | 3.15 | 6.33 | 30.70 | 30.99 | 2.75 | 5.48 | -- | -- | 0.2603 | 50.10 | -1.67 | 1.70 | -66.32 | -9.86 | -10.18 | 4.56 |
AnGes Inc | 249.94m | -6.35bn | 10.30bn | 145.00 | -- | 0.3616 | -- | 41.22 | -32.62 | -32.62 | 1.29 | 124.45 | 0.0077 | 0.0862 | 4.77 | 1,723,752.00 | -19.47 | -28.50 | -23.06 | -33.14 | 39.85 | 39.42 | -2,540.59 | -6,726.82 | 0.9124 | -- | 0.0139 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
Data as of Jun 07 2024. Currency figures normalised to CellSeed Inc's reporting currency: Japanese Yen JPY
Holder | Shares | % Held |
---|---|---|
Barclays Bank Plc (Investment Management)as of 16 May 2024 | 2.20m | 6.84% |
Simplex Asset Management Co., Ltd.as of 09 May 2024 | 144.70k | 0.45% |
Data from 16 May 2024 - 24 May 2024Source: FactSet Research Systems Inc.